Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan... see more

Recent & Breaking News (CSE:COOL)

World Renowned Physician Joins Core One Labs as Chief Medical Officer

GlobeNewswire May 5, 2021

Core One Labs Unaware of Any Material Change that Would Account for Significant Share Price Depreciation

Accesswire May 4, 2021

REPEAT - Core One Labs Completes Milestone Acquisition of Akome Biotech

GlobeNewswire May 4, 2021

Core One Labs Appoints Patent Expert, Dr. Dan Polonenko, To Advisory Board

Accesswire April 29, 2021

REPEAT -- Core One Labs Reaches Definitive Agreement to Acquire Akome Biotech

GlobeNewswire April 29, 2021

Core One Labs (CSE:COOL) reaches agreement to acquire Akome Biotech

John Ballem  April 29, 2021

Core One Labs Reaches Definitive Agreement to Acquire Akome Biotech

GlobeNewswire April 29, 2021

Lobe Sciences (CSE:LOBE) enters into joint venture with Core One Labs (CSE:COOL) for the development of psychedelic compounds

Julia Kennedy  April 28, 2021

REPEAT -- Core One Labs to Explore Joint Venture with Lobe Sciences for the Clinical Development of Biosynthetic Psilocybin

GlobeNewswire April 28, 2021

Core One Labs to Explore Joint Venture with Lobe Sciences for the Clinical Development of Biosynthetic Psilocybin

GlobeNewswire April 28, 2021

Core One Labs (CSE:COOL) subsidiary enters into collaborative research agreement with UBC

Trevor Abes  April 26, 2021

Repeat: Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC

GlobeNewswire April 26, 2021

Emerging Markets Report: The Rich Get Richer

GlobeNewswire April 26, 2021

Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC

GlobeNewswire April 24, 2021

Core One Labs’ (CSE:COOL) initiates the engineering and design of a proprietary production system

Brieanna McCutcheon  April 21, 2021

REPEAT: Core One Labs' Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT

GlobeNewswire April 21, 2021

Core One Labs' Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT

GlobeNewswire April 21, 2021

Core One Labs Negotiates Milestone Acquisition With Akome Biotech Ltd.

Accesswire April 17, 2021

Core One Labs to Rescind Share Exchange with Plant-Based Investment Corp.

Accesswire April 14, 2021

Emerging Markets Report: A Moment for the Mushroom

GlobeNewswire April 14, 2021